Physician profile
Genaro J Gutierrez
NPI 1396971826
$124,854.58
in general payments reported to CMS, 2019-2025
41 companies · $7,897 in 2025
The $7,897 reported for 2025 was more than what 93% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $12K · 2021: $11K · 2022: $36K · 2023: $32K · 2024: $13K · 2025: $7,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $13K · Travel and Lodging: $8,168 · Charitable Contribution: $4,900 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,225.00 |
| Food and Beverage | $12,909.96 |
| Travel and Lodging | $8,167.90 |
| Charitable Contribution | $4,900.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $66,579.66 | 2019-2025 | Sprint Pns System |
| Boston Scientific Corporation | $25,707.04 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $8,520.24 | 2019-2025 | Proclaim, Octrode, Eterna |
| Si-Bone, INC. | $7,784.76 | 2019-2025 | |
| Nalu Medical, INC. | $4,927.98 | 2020-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $2,674.11 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Primeadvanced Surescan |
| Biotronik Nro, INC. | $2,279.82 | 2023-2024 | Prospera, Biotronik |
| Relievant Medsystems, INC. | $1,423.79 | 2021-2023 | Intracept |
| Nevro Corp. | $860.49 | 2019-2023 | Senza |
| Vertiflex, INC. | $550.96 | 2019 | |
| Abbvie INC. | $433.19 | 2021-2025 | |
| Bioventus LLC | $385.42 | 2020-2023 | Stimrouter Implantable Kit |
| Spinal Simplicity, LLC | $362.04 | 2022-2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $278.59 | 2019-2025 | Belbuca, Xtampza |
| Medtronic USA, INC. | $269.24 | 2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genaro Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.